BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34555929)

  • 1. Improvement in Kansas City Cardiomyopathy Questionnaire Scores After a Self-Care Intervention in Patients With Acute Heart Failure Discharged From the Emergency Department.
    Stubblefield WB; Jenkins CA; Liu D; Storrow AB; Spertus JA; Pang PS; Levy PD; Butler J; Chang AM; Char D; Diercks DB; Fermann GJ; Han JH; Hiestand BC; Hogan CJ; Khan Y; Lee S; Lindenfeld JM; McNaughton CD; Miller K; Peacock WF; Schrock JW; Self WH; Singer AJ; Sterling SA; Collins SP
    Circ Cardiovasc Qual Outcomes; 2021 Oct; 14(10):e007956. PubMed ID: 34555929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Self-care Intervention on 90-Day Outcomes in Patients With Acute Heart Failure Discharged From the Emergency Department: A Randomized Clinical Trial.
    Collins SP; Liu D; Jenkins CA; Storrow AB; Levy PD; Pang PS; Chang AM; Char D; Diercks DJ; Fermann GJ; Han JH; Hiestand B; Hogan C; Kampe CJ; Khan Y; Lee S; Lindenfeld J; Martindale J; McNaughton CD; Miller KF; Miller-Reilly C; Moser K; Peacock WF; Robichaux C; Rothman R; Schrock J; Self WH; Singer AJ; Sterling SA; Ward MJ; Walsh C; Butler J
    JAMA Cardiol; 2021 Feb; 6(2):200-208. PubMed ID: 33206126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Impact of Routine Assessment of Patient-Reported Health Status in Heart Failure Clinic: The PRO-HF Trial.
    Sandhu AT; Calma J; Skye M; Kalwani N; Zheng J; Schirmer J; Din N; Brown Johnson C; Gupta A; Lan R; Yu B; Spertus JA; Heidenreich PA
    Circulation; 2024 May; 149(22):1717-1728. PubMed ID: 38583147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Results of the Patient-Centered Disease Management (PCDM) for Heart Failure Study: A Randomized Clinical Trial.
    Bekelman DB; Plomondon ME; Carey EP; Sullivan MD; Nelson KM; Hattler B; McBryde CF; Lehmann KG; Gianola K; Heidenreich PA; Rumsfeld JS
    JAMA Intern Med; 2015 May; 175(5):725-32. PubMed ID: 25822284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial.
    Kosiborod MN; Jhund PS; Docherty KF; Diez M; Petrie MC; Verma S; Nicolau JC; Merkely B; Kitakaze M; DeMets DL; Inzucchi SE; Køber L; Martinez FA; Ponikowski P; Sabatine MS; Solomon SD; Bengtsson O; Lindholm D; Niklasson A; Sjöstrand M; Langkilde AM; McMurray JJV
    Circulation; 2020 Jan; 141(2):90-99. PubMed ID: 31736335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life assessment for acute heart failure patients from emergency department presentation through 30 days after discharge: A pilot study with the Kansas City Cardiomyopathy Questionnaire.
    Sauser K; Spertus JA; Pierchala L; Davis E; Pang PS
    J Card Fail; 2014 May; 20(5):378.e11-5. PubMed ID: 25089314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Telemonitoring on Health Status.
    Jayaram NM; Khariton Y; Krumholz HM; Chaudhry SI; Mattera J; Tang F; Herrin J; Hodshon B; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2017 Dec; 10(12):. PubMed ID: 29237746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry.
    Khariton Y; Hernandez AF; Fonarow GC; Sharma PP; Duffy CI; Thomas L; Mi X; Albert NM; Butler J; McCague K; Nassif ME; Williams FB; DeVore A; Patterson JH; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004668. PubMed ID: 29627798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the DELIVER Trial.
    Peikert A; Chandra A; Kosiborod MN; Claggett BL; Desai AS; Jhund PS; Lam CSP; Inzucchi SE; Martinez FA; de Boer RA; Hernandez AF; Shah SJ; Janssens SP; Belohlávek J; Borleffs CJW; Dobreanu D; Langkilde AM; Bengtsson O; Petersson M; McMurray JJV; Solomon SD; Vaduganathan M
    JAMA Cardiol; 2023 Jul; 8(7):684-690. PubMed ID: 37208998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial.
    Kosiborod MN; Angermann CE; Collins SP; Teerlink JR; Ponikowski P; Biegus J; Comin-Colet J; Ferreira JP; Mentz RJ; Nassif ME; Psotka MA; Tromp J; Brueckmann M; Blatchford JP; Salsali A; Voors AA
    Circulation; 2022 Jul; 146(4):279-288. PubMed ID: 35377706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial.
    Butler J; Filippatos G; Jamal Siddiqi T; Brueckmann M; Böhm M; Chopra VK; Pedro Ferreira J; Januzzi JL; Kaul S; Piña IL; Ponikowski P; Shah SJ; Senni M; Vedin O; Verma S; Peil B; Pocock SJ; Zannad F; Packer M; Anker SD
    Circulation; 2022 Jan; 145(3):184-193. PubMed ID: 34779658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adapting and usability testing of the Kansas city cardiomyopathy questionnaire (KCCQ) in a heart failure clinic in Tanzania: the Swahili KCCQ.
    Chillo P; Mlay J; Akanyirige PW; Majani N; Janabi M; Kaaya S; Hawkins C; Hirschhorn LR
    BMC Cardiovasc Disord; 2023 May; 23(1):242. PubMed ID: 37149565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life assessment for acute heart failure patients from emergency department presentation through 30 days after discharge: a pilot study with the Kansas City Cardiomyopathy Questionnaire.
    Sauser K; Spertus JA; Pierchala L; Davis E; Pang PS
    J Card Fail; 2014 Jan; 20(1):18-22. PubMed ID: 24296380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Patient-Reported Outcome Measurement in Heart Failure Clinic on Clinician Health Status Assessment and Patient Experience: A Substudy of the PRO-HF Trial.
    Sandhu AT; Zheng J; Kalwani NM; Gupta A; Calma J; Skye M; Lan R; Yu B; Spertus JA; Heidenreich PA
    Circ Heart Fail; 2023 Feb; 16(2):e010280. PubMed ID: 36334312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-Stay Units vs Routine Admission From the Emergency Department in Patients With Acute Heart Failure: The SSU-AHF Randomized Clinical Trial.
    Pang PS; Berger DA; Mahler SA; Li X; Pressler SJ; Lane KA; Bischof JJ; Char D; Diercks D; Jones AE; Hess EP; Levy P; Miller JB; Venkat A; Harrison NE; Collins SP
    JAMA Netw Open; 2024 Jan; 7(1):e2350511. PubMed ID: 38198141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an Early Palliative Care Telehealth Intervention vs Usual Care on Patients With Heart Failure: The ENABLE CHF-PC Randomized Clinical Trial.
    Bakitas MA; Dionne-Odom JN; Ejem DB; Wells R; Azuero A; Stockdill ML; Keebler K; Sockwell E; Tims S; Engler S; Steinhauser K; Kvale E; Durant RW; Tucker RO; Burgio KL; Tallaj J; Swetz KM; Pamboukian SV
    JAMA Intern Med; 2020 Sep; 180(9):1203-1213. PubMed ID: 32730613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
    Greene SJ; Velazquez EJ; Anstrom KJ; Clare RM; DeWald TA; Psotka MA; Ambrosy AP; Stevens GR; Rommel JJ; Alexy T; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Eisenstein EL; Mentz RJ;
    Circulation; 2023 Jul; 148(2):124-134. PubMed ID: 37212600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated E-Counseling for Chronic Heart Failure: CHF-CePPORT Trial.
    Nolan RP; Ross HJ; Farkouh ME; Huszti E; Chan S; Toma M; D'Antono B; White M; Thomas S; Barr SI; Perreault S; McDonald M; Zieroth S; Isaac D; Wielgosz A; Mielniczuk LM
    Circ Heart Fail; 2021 Jan; 14(1):e007073. PubMed ID: 33464959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial.
    Kosiborod MN; Verma S; Borlaug BA; Butler J; Davies MJ; Jon Jensen T; Rasmussen S; Erlang Marstrand P; Petrie MC; Shah SJ; Ito H; Schou M; Melenovský V; Abhayaratna W; Kitzman DW;
    Circulation; 2024 Jan; 149(3):204-216. PubMed ID: 37952180
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.